AI Blood Smear Analysis Software
Aid in diagnosis of blood disorders (e.g., anemia, leukemia, infection)
Development & ValidationActive
Key Facts
Indication
Aid in diagnosis of blood disorders (e.g., anemia, leukemia, infection)
Phase
Development & Validation
Status
Active
Company
About Hemorai
Founded in 2018 and headquartered in San Francisco, Hemorai is a private, pre-revenue company focused on AI-powered diagnostic software for hematology. Its core platform uses machine learning algorithms to analyze peripheral blood smear images, potentially improving the speed, accuracy, and consistency of diagnosing blood disorders like anemias, leukemias, and infections. The company targets the clinical laboratory and digital pathology markets, aiming to integrate its software as an aid within existing diagnostic workflows.
View full company profile